Jessica Tuan
Overview
Explore the profile of Jessica Tuan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
78
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tuan J
BMJ Case Rep
. 2025 Jan;
18(1.
PMID: 39828326
An African American man in his early 40s with progressive gait impairment and chronic cognitive impairment initially presented to the emergency department after statements of self-harm and was hospitalised. Examination...
2.
Tuan J, Igiraneza G, Ogbuagu O
Expert Opin Drug Metab Toxicol
. 2024 Sep;
20(10):953-965.
PMID: 39230187
Background: People with HIV (PWH) are living longer directly related to benefits of highly effective antiretroviral therapy (ART). However, concurrent with improved longevity is the growing prevalence of metabolic comorbidities...
3.
Tuan J, Goheen M, Trebelcock W, Dunne D
Infect Dis Clin North Am
. 2024 Jun;
38(3):559-579.
PMID: 38871569
Sexually transmitted infections (STIs) are more commonly seen in patients with human immunodeficiency virus (PWH). Routine sexual history taking and appropriate multisite screening practices support prompt identification and treatment of...
4.
Sherman A, Tuan J, Cantos V, Adeyiga O, Mahoney S, Ortega-Villa A, et al.
Clin Infect Dis
. 2024 Apr;
79(2):364-374.
PMID: 38598658
Background: Although the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines are highly efficacious at preventing severe disease in the general population, current data are lacking regarding vaccine efficacy (VE)...
5.
Tuan J, Okoli A, Ogbuagu O
Expert Opin Drug Metab Toxicol
. 2023 Dec;
19(12):881-888.
PMID: 38058292
Introduction: The World Health Organization proposed targets to eliminate hepatitis C virus (HCV) by 2030, aiming to treat ≥80% of people with HCV, decreasing new chronic infections by 90% and...
6.
Tuan J, Ogbuagu O
Expert Rev Anti Infect Ther
. 2023 Apr;
21(6):565-570.
PMID: 37067160
Introduction: Lenacapavir, the compound reviewed in this paper, is a novel, potent, and long-acting first-in-class HIV-1 capsid inhibitor that was granted a breakthrough therapy designation for HIV treatment by the...
7.
Ogbuagu O, Sharma M, Igiraneza G, Andrews L, Tuan J, Barakat L
BMC Infect Dis
. 2023 Apr;
23(1):224.
PMID: 37046201
No abstract available.
8.
Ogbuagu O, Sharma M, Igiraneza G, Andrews L, Tuan J, Barakat L
BMC Infect Dis
. 2023 Mar;
23(1):146.
PMID: 36890468
Background: Our study survey assessed HIV risk profile and pre-exposure prophylaxis (PrEP) use among HIV-negative individuals seeking mpox vaccination, elucidating HIV prevention gaps and opportunities. Methods: Anonymous cross-sectional surveys were...
9.
Brown S, Cormier J, Tuan J, Lier A, McGuone D, Armstrong P, et al.
Emerg Infect Dis
. 2021 Jul;
27(8).
PMID: 34289334
No abstract available.
10.
Pischel L, Walelo M, Benson J, Osborn R, Schrier R, Tuan J, et al.
PLoS One
. 2021 May;
16(5):e0250735.
PMID: 33956849
As the Coronavirus-2019 (COVID-19) pandemic continues, multiple therapies are rapidly being evaluated for efficacy in clinical trials. Clinical trials should be racially and ethnically representative of the population that will...